- Home
- IMMX vs DSWL Comparison
IMMX vs DSWL Comparison
Compare IMMX & DSWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- DSWL
- Stock Information
- Founded
- IMMX 2014
- DSWL 1987
- Country
- IMMX United States
- DSWL Macau
- Employees
- IMMX N/A
- DSWL 794
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- DSWL Plastic Products
- Sector
- IMMX Health Care
- DSWL Industrials
- Exchange
- IMMX Nasdaq
- DSWL Nasdaq
- Market Cap
- IMMX 65.5M
- DSWL 64.1M
- IPO Year
- IMMX 2021
- DSWL 1995
- Fundamental
- Price
- IMMX $2.00
- DSWL $3.89
- Analyst Decision
- IMMX Strong Buy
- DSWL
- Analyst Count
- IMMX 1
- DSWL 0
- Target Price
- IMMX $8.00
- DSWL N/A
- AVG Volume (30 Days)
- IMMX 183.0K
- DSWL 42.8K
- Earning Date
- IMMX 11-11-2025
- DSWL 11-14-2025
- Dividend Yield
- IMMX N/A
- DSWL 4.91%
- EPS Growth
- IMMX N/A
- DSWL 45.62
- EPS
- IMMX N/A
- DSWL 0.70
- Revenue
- IMMX N/A
- DSWL $67,610,000.00
- Revenue This Year
- IMMX N/A
- DSWL N/A
- Revenue Next Year
- IMMX N/A
- DSWL N/A
- P/E Ratio
- IMMX N/A
- DSWL $5.75
- Revenue Growth
- IMMX N/A
- DSWL N/A
- 52 Week Low
- IMMX $1.26
- DSWL $1.93
- 52 Week High
- IMMX $3.20
- DSWL $4.48
- Technical
- Relative Strength Index (RSI)
- IMMX 48.92
- DSWL 53.86
- Support Level
- IMMX N/A
- DSWL $4.12
- Resistance Level
- IMMX $2.34
- DSWL $4.40
- Average True Range (ATR)
- IMMX 0.15
- DSWL 0.20
- MACD
- IMMX -0.08
- DSWL -0.04
- Stochastic Oscillator
- IMMX 85.11
- DSWL 20.67
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About DSWL Deswell Industries Inc.
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.